
Share on:
Mobelife and JRI Orthopaedics will collaborate to grow Mobelife’s aMace® Acetabular Revision System business further in the UK and Ireland. aMace is designed to offer complete personalization to both patient and surgeon.
Mobelife’s solution for hip revisions will join JRI’s lower limb portfolio, a range of implants and instruments including the Furlong hip stem. Mobelife, part of the Materialise Group, offers a completely customized product development process for patient-specific orthopaedic implants.
Source: Mobelife NV
RELATED ARTICLES
AVNA Names Chip Harvill as Senior Business Development Executive
May 05 2025 , Julie A. Vetalice
Lincotek and Promimic Enter Strategic License Agreement
Apr 23 2025 , Julie A. Vetalice
Trump’s Tariffs Offer Opportunity for Supply Chain Improvement
Apr 23 2025 , BONEZONE Editors